Advertisement

Topics

Companies Related to "Hemostasis in Sickle Cell Disease--Infancy to Adulthood" [Most Relevant Company Matches] RSS

01:17 EST 22nd February 2019 | BioPortfolio

Here are the most relevant search results for "Hemostasis in Sickle Cell Disease--Infancy to Adulthood" found in our extensive corporate database of over 50,000 company records.

Showing "Hemostasis Sickle Cell Disease Infancy Adulthood" Companies 1–25 of 3,800+

Relevant

Imara Inc.

Imara Inc., a Cydan Development company, is dedicated to developing novel therapeutics for patients with sickle cell disease. Imara is developing IMR-687, a highly selective, potent small molecule inhibitor of PDE9, to treat patients with sickle cell disease. The company was launched following an 18-month diligence and de-risking scientific collabor...


Sickle Cell Foundation of Tennessee

“Our mission is to provide social services, including health, education and life skills, to enhance the quality of life and self-sufficiency of individuals living with Sickle Cell,” said Thompson. “Everything we plan builds our capacity and extends our reach to serve more people. We must grow because there are people in pain who need our help.â€...

Emmaus Life Sciences, Inc.

Emmaus Life Sciences is dedicated to the discovery, development and commercialization of innovative treatments and therapies for rare diseases. The Company’s research on sickle cell disease and sickle beta-0 thalassemia was initiated by Dr. Niihara at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. The therapy has Orphan D...


Hemostasis Reference Laboratory Hamilton Civic Hospitals Research Centre

The Hemostasis Reference Laboratory is located in the Hamilton Civic Hospitals Research Centre, Hamilton, Ontario, Canada. In addition to our research focus, we provide a full range of specialised hemostasis testing for the following: clinical trials testing, validation of hemostasis equipment (including point-of-care), testing/validation of hemostasis reagents, ISI assignments against WHO stand...

Children's Healthcare of Atlanta

Congenital heart defects are the most common birth defect, affecting one in 100 newborns each year. Treating nearly 30,000 children every year, the Children's Healthcare of Atlanta Sibley Heart Center has garnered widespread national recognition for our innovative treatments, leading-edge research and compassionate care. And, in 2005, the Children's Sibley Heart Center was named one of the country...

National Stomp Out Sickle Cell Walk

The William E. Proudford Sickle Cell Fund

Angiogenix, Inc.

Angiogenix is a biopharmaceutical company developing therapeutic solutions for chronic vascular disease. We are a product-oriented company. Our products generally address the improvement of blood flow by improving vascular function. Within this framework, our products cover a broad range of types and indications, from novel combination drugs to a new proprietary drug for sickle cell disease. We al...

Autism Spectrum Therapies

Founded by respected experts in the field of autism, Autism Spectrum Therapies (AST) provides individuals with autism with a range of services from infancy through adulthood, as well as comprehensive training and support for parents and families in their homes and communities. AST's highly trained clinical staff uses scientifically-validated methods grounded in the principles of Applied Behavior A...

HopeLab

HopeLab is a non-profit organization founded in 2001 by Board Chair Pam Omidyar. HopeLab combines rigorous research with innovative solutions to improve the health and quality of life of young people living with chronic illness. HopeLab applies a research-based, customer-focused development model to create products that address chronic illnesses in young people, including cancer, obesity, sic...

Celtor Biosystems A/S

CelTor is a product-based biotechnology company engaged in the discovery and development of novel drug compounds for the treatment of inflammatory disease using its proprietary CelBase™ Disease Models. These disease models replicate cell-to-cell interactions that are critical in the inflammation cascade.

Instrumentation Laboratory

Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM® product offerings, par...

Selexys Pharmaceuticals Corporation

Selexys Pharmaceuticals Corporation (Selexys) is a privately held company that develops and commercializes therapeutics to treat inflammatory and thrombotic diseases. The company has completed research and is in preclinical development of two drug candidates, a monoclonal antibody and a glycosulfopeptide, that have broad application for the treatment of acute and chronic inflammatory disorders. Th...

Medinox, Inc

Medinox, Inc. is a San Diego-based pharmaceutical company that is developing new small molecule drugs to treat a wide variety of unmet medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The Company's research and clinical development programs fall into two broad categories: 1) nitric oxide neutralizers, and 2) novel prodrugs.

Hemostasis Reference Laboratory

AMJ Laboratory Services Ltd was incorporated in 1990. The laboratory was originally situated in Guelph Ontario and moved to the Henderson Research Centre in 1994. To better reflect our work, the name Hemostasis Reference Laboratory was registered with the Ontario Government and is used for all contracts, advertisements and publications. Since our move to Hamilton, we have enjoyed steady growth an...

BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that: * Address currently unmet medical needs * Suggest a clear-cut development profile * Provide an opportunity to be first-to-market The company's product portfolio is comprised of three approved products and multiple investigational product...

DeuteRx LLC

DeuteRx is pioneering ‘deuterium-enabled chiral switching’ (DECS), a revolutionary approach to improve racemic (a mixture of two mirror-image compounds or enantiomers) small molecule marketed drugs and drug candidates intended for patients across multiple therapeutic indications. Numerous drugs are still developed and marketed as racemic mixtures...

Marine Polymer Technologies, Inc.

Marine Polymer Technologies (MPT) is a privately-held medical device company that researches, develops and markets technologies for patient hemostasis and wound healing based on a proprietary microalgae-based polymer. In addition to Talymed, MPT products include Syvek Excel® Vascular Access Hemostasis System for use following...

U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc. is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development and commercialization of cell-based therapies that prevent or treat disease by repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

Opsis Therapeutics

Opsis Therapeutics is a company focused on discovering and developing new medicines to restore vision to patients suffering from retinal diseases. By combining recent innovations in induced pluripotent cell (iPSC) manufacturing, retinal cell differentiation, functional biomaterials, pre-clinical models of retinal disease, and cell therapeutic delivery tech...

bluebird bio, Inc.

bluebird bio is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of novel treatments for diseases with few or no clinical options. The company’s novel approach uses stem cells harvested from the patientâ...

Bio-Boston Contract laboratories

Preclinical contract services R&D, HPLC, Peptide Synthesis, Purification, ELISA, Chemiluminescent assays, bioassays, analytical chemistry, cell culture, tissue culture, Biochemistry, synthesis, formulation support, Neuroscience, bioanalytical, methods development, LAL Endotoxin testing, sequencing, Molecular Biology, Cell Biology, Cell based Assays, Immunochemistry, chemical analysies, biochemical...

National Stem Cell Holding, Inc.

National Stem Cell Holding, Inc. is a biotechnology company focused on the development and commercialization of cell therapeutics primarily for diabetes and cardiac disease, and cosmetics derived from stem cells. For more information, visit http://www.proteoderm.com, and http://www.proteonomix.com.

Cell Therapy Foundation

The Cell Therapy Foundation is a not-for-profit organization committed to advancing the treatment of disease using adult stem cells. Emerging as a leader in raising funds for adult stem cell research, Cell Therapy Foundation strives to increase awareness about adult stem cells, to fund adult stem cell research addressing several specific diseases, and to accelerate the rate of research and clini...

Univec, Inc.

Univec, Inc., a minority business enterprise (MBE), is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost products that are not usually dispensed in retail pharmacies but require special handling and a complex pharmaceutical regime. The company is focused on dise...


More From BioPortfolio on "Hemostasis in Sickle Cell Disease--Infancy to Adulthood"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks